Patients without electrocardiographic (ECG) evidence of left ventricular hypertrophy were significantly more likely to die in the two years after transcatheter aortic valve replacement (TAVR), researchers reported July 30 in Clinical Cardiology.

A group of researchers from a Veterans Affairs health system in California shared their experience with limited left ventricular echocardiography, something they believe could reduce the cost and time required for testing in select patients.

Optical coherence tomography (OCT) can detect coronary vascular changes beyond the capabilities of angiography in pediatric heart transplant recipients, according to a study published July 18 in JACC: Cardiovascular Imaging.

Twice as many U.S. deaths due to cardiac amyloidosis were reported in 2015 than in 1979, but a study in JAMA Cardiology suggests the disease remains vastly underdiagnosed.

A quantification of myocardial blood flow using CT perfusion (CTP) imaging was strongly predictive of major adverse cardiac events (MACE) and offered additional prognostic ability when added to coronary CT angiography, researchers reported in JACC: Cardiovascular Imaging.

Interest in Tc 99m PYP is growing as new therapies for cardiac amyloidosis show promise in late-stage clinical trials.

Quantitative flow ratio (QFR) allows for the functional assessment of stenosis on par with fractional flow reserve (FFR) but doesn’t require a guidewire, an international group of researchers reported in the Journal of the American Heart Association.

Individuals at high risk for atrial fibrillation (AFib) who utilized a home-based wearable electrocardiogram (ECG) patch had a higher rate of AFib diagnosis after four months compared to delayed monitoring.